
Kisunla Approved by FDA, 2nd Drug to Actually Slow Alzheimer’s
VIDEO + ARTICLE: Kisunla (generic name: Donanemab) slowed cognitive and functional decline 35%. Once-monthly infusions reduced Alzheimer’s plaque 84%.

VIDEO + ARTICLE: Kisunla (generic name: Donanemab) slowed cognitive and functional decline 35%. Once-monthly infusions reduced Alzheimer’s plaque 84%.

China is the third country to launch LEQEMBI for sale, to fight Alzheimer’s, following the United States and Japan.

Three FDA-Approved drugs, terazosin, doxazosin, and alfuzosin, have a happy side effect; they boost energy production in brain cells. New studies suggest this slows or prevents Dementia with Lewy Bodies.

Grandma hates taking her medications. With her dementia, she ends up asking 10 different times why she has to take it! What should I do?

The unanimous 11-0 FDA vote clears an exciting path for this new Alzheimer’s drug.

South Korea joined other countries in approving LEQEMBI® (generic lecanemab) for mild cognitive impairment, mild and early Alzheimer’s. Learn how Leqembi is treating Alzheimer’s around the world.

“People with dementia living in nursing homes and in the community were prescribed less and we did not detect negative health impacts for these groups.”

LEQEMBI® is the newest Alzheimer’s drug. It is administered in hospitals via IV. Biogen applied to the FDA for approval of a home version using an “Autoinjector”. See how it works and learn its advantages.

The first doses of the newly approved Alzheimer’s drug “Leqembi” were administered in Louisville. More than 100 people have signed up since then. See why.

Biogen reprioritize resources allocated to ADUHELM® to advance LEQEMBI®.

DEMENTIA GIFT IDEAS: People with Alzheimer’s may lose abilities, but feelings still matter. What once wasn’t much of a gift, may now be a great one. What were nice presents may no longer be right. See these thoughtful suggestions.

Alzheimer’s treatment eligibility may be far larger than previously thought. A major Nature study using blood tests suggests millions more older adults could qualify for treatment than current use reflects. As diagnosis becomes easier, demand for drugs like Leqembi could shift sharply.

Israel pairs the developed world’s highest birth rate with the lowest crude dementia prevalence in a major European comparison—an advantage rooted in demographics that gives the country valuable time to prepare better for caregivers and families.

It is one of the most beautiful Compensations of this life thatNo man can sincerely try to help anotherWithout helping himself.

What are the early symptoms of Alzheimer’s? When to get a professional evaluation.

SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.

Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
No spam, only news and updates.


